《anti-tuberculosis》怎以读
英 ['ænti:tju:bɜ:kjʊl'əʊsɪs]
00:00/00:00
美 ['æntitjubɜkjʊl'oʊsɪs]
00:00/00:00
《anti-tuberculosis》是什么意思
抗痨剂；
学习《anti-tuberculosis》怎么用
权威例句
Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated ...
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resist...
Anti-tuberculosis drug resistance in the World
Anti-tuberculosis drug resistance in the world. Third global report. The WHO / IUATLD Global Project on Anti-Tuberculosis Drug Resis...
Anti-tuberculosis drug resistance in the world. Report No. 4: The WHO/IUATLD global project on anti-tuberculosis drug resistance sur...
Anti-tuberculosis drug resistance in the world: fourth global report
Epidemiology of antituberculosis drug resistance 2002鈥 an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistan...
Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010.
Chalcones and flavonoids as anti-tuberculosis agents
Prevalence of anti-tuberculosis drug resistance in an HIV/AIDS reference hospital in Rio de Janeiro, Brazil.
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resist...
Anti-tuberculosis drug resistance in the World
Anti-tuberculosis drug resistance in the world. Third global report. The WHO / IUATLD Global Project on Anti-Tuberculosis Drug Resis...
Anti-tuberculosis drug resistance in the world. Report No. 4: The WHO/IUATLD global project on anti-tuberculosis drug resistance sur...
Anti-tuberculosis drug resistance in the world: fourth global report
Epidemiology of antituberculosis drug resistance 2002鈥 an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistan...
Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010.
Chalcones and flavonoids as anti-tuberculosis agents
Prevalence of anti-tuberculosis drug resistance in an HIV/AIDS reference hospital in Rio de Janeiro, Brazil.